CELEGHINI, Claudio
CELEGHINI, Claudio
Dipartimento di Medicina Traslazionale e per la Romagna
Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B-CLL) cells.
file con accesso da definire2005 Secchiero, Paola; Tiribelli, M; Barbarotto, Elisa; Celeghini, C; Michelutti, A; Masolini, P; Fanin, R; Zauli, Giorgio
Activation of PKC-epsilon counteracts maturation and apoptosis of HL-60 myeloid leukemic cells in response to TNF family members
file con accesso da definire2009 Gonelli, Arianna; Milani, Daniela; Rimondi, Erika; Voltan, Rebecca; Grill, V; Celeghini, C.
Activation of the nitric oxide synthase pathway represents a key component of the TNF-related apoptosis-inducing ligand (TRAIL)-mediated cytotoxicity on hematological malignancies.
file con accesso da definire2001 Secchiero, Paola; Gonelli, Arianna; Celeghini, Claudio; Mirandola, Prisco; Guidotti, L; Visani, G; Capitani, Silvano; Zauli, Giorgio
All-Trans retinoic acid potentiates megakaryocyte colony formation: in vitro and in vivo effects after administration to acute promyelocytic leukemia patients
file con accesso da definire1994 Visani, G.; Zauli, G.; Tosi, P.; Ottaviani, E.; Gibellini, D.; Manfroi, S.; Celeghini, C.; Pagliarini, C.; Bassini, A.; Tura, S.
An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction
file con accesso da definire2006 Secchiero, Paola; Corallini, Federica; Pandolfi, A; Consoli, A; Candido, R; Fabris, B; Celeghini, C; Capitani, Silvano; Zauli, Giorgio
An update on the xenograft and mouse models suitable for investigating new therapeutic compounds for the treatment of B-cell malignancies
file con accesso da definire2008 Macor, P.; Secco, E.; Zorzet, S.; Tripodo, C.; Celeghini, C.; Tedesco, F.
Anti-leukemic activity of Dasatinib in both p53(wild-type) and p53 (mutated) B malignant cells.
file con accesso da definire2012 Bosco, Raffaella; Rabusin, M; Voltan, Rebecca; Celeghini, C; Corallini, Federica; Capitani, Silvano; Secchiero, Paola
Association of PI 3-K with tyrosine phosphorylated Vav is essential for its activity in neutrophil-like maturation of myeloid cells
2004 Bertagnolo, Valeria; Brugnoli, Federica; Marchisio, Marco; Celeghini, Claudio; Carini, Cinzia; Capitani, Silvano
Association of serum tumor necrosis factor-related apoptosis inducing ligand with body fat distribution as assessed by dual X-rays absorptiometry
file con accesso da definire2014 Cervellati, Carlo; Secchiero, Paola; Bonaccorsi, Gloria; Celeghini, C; Zauli, Giorgio
Ceramides as the molecular link between impaired lipid metabolism, saturated fatty acid intake and insulin resistance: are all saturated fatty acids to be blamed for ceramide-mediated lipotoxicity?
file con accesso da definire2024 Sergi, D.; Zauli, E.; Celeghini, C.; Previati, M.; Zauli, G.
Complement component C1q as potential diagnostic but not predictive marker of preeclampsia
2016 Agostinis, C.; Stampalija, T.; Tannetta, D.; Loganes, C.; Vecchi Brumatti, L.; De Seta, F.; Celeghini, C.; Radillo, O.; Sargent, I.; Tedesco, F.; Bulla, R.
Design, synthesis and biological characterization of novel mitochondria targeted dichloroacetate-loaded compounds with antileukemic activity
2016 Trapella, Claudio; Voltan, Rebecca; Melloni, Elisabetta; Tisato, Veronica; Celeghini, C; Bianco, Sara; Fantinati, Anna; Salvadori, Severo; Guerrini, Remo; Secchiero, Paola; Zauli, Giorgio
Dexamethasone counteracts the anti-osteoclastic, but not the anti-leukemic, activity of TNF-related apoptosis inducing ligand (TRAIL)
file con accesso da definire2010 Zauli, Giorgio; Rimondi, Erika; Celeghini, C; Milani, Daniela; Secchiero, Paola
Differential effects of chemotherapeutic drugs versus the MDM-2 antagonist nutlin-3 on cell cycle progression and induction of apoptosis in SKW6.4 lymphoblastoid B-cells
file con accesso da definire2008 Barbarotto, Elisa; Corallini, Federica; Rimondi, Erika; Fadda, Roberto; Mischiati, Carlo; Grill, V; Vaccarezza, M; Celeghini, Claudio
Differential effects of stromal derived factor-1 alpha (SDF-1alpha) on early and late stages of human megakaryocytic development.
file con accesso da definire2000 Secchiero, Paola; Celeghini, Claudio; Cutroneo, G; DI BALDASSARRE, A; Rana, R; Zauli, Giorgio
Effect of recombinant TRAIL in a murine co-culture system of osteoclastogenesis
file con accesso da definire2008 Nicolin, V; Narducci, P; Celeghini, C
Erythropoietin-induced erythroid differentiation of K562 cells is accompanied by the nuclear translocation of phosphatidylinositol 3-kinase and intranuclear generation of phosphatidylinositol (3,4,5) trisphosphate
file con accesso da definire2002 Neri, Luca Maria; Bortul, R; Tabellini, G; Borgatti, Paola; Baldini, G; Celeghini, Claudio; Capitani, Silvano; Martelli, Am
Extracellular Tat activates c-fos promoter in low serum-starved CD4+ T cells
file con accesso da definire2001 Gibellini, D; Re, Mc; Ponti, C; Celeghini, C; Melloni, E; LA PLACA, M; Zauli, G
Fine tuning of protein kinase C (PKC) isoforms in cancer: shortening the distance from the laboratory to the bedside.
file con accesso da definire2011 Bosco, Raffaella; Melloni, Elisabetta; Celeghini, C; Rimondi, Erika; Vaccarezza, M; Zauli, Giorgio
Functional expression of TRAIL and TRAIL-R2 during human megakaryocytic development
file con accesso da definire2005 Melloni, Elisabetta; Secchiero, Paola; Celeghini, C; Campioni, Diana; Grill, V; Guidotti, L; Zauli, Giorgio
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B-CLL) cells. | 2005 | Secchiero, Paola; Tiribelli, M; Barbarotto, Elisa; Celeghini, C; Michelutti, A; Masolini, P; Fani...n, R; Zauli, Giorgio | file con accesso da definire |
Activation of PKC-epsilon counteracts maturation and apoptosis of HL-60 myeloid leukemic cells in response to TNF family members | 2009 | Gonelli, Arianna; Milani, Daniela; Rimondi, Erika; Voltan, Rebecca; Grill, V; Celeghini, C. | file con accesso da definire |
Activation of the nitric oxide synthase pathway represents a key component of the TNF-related apoptosis-inducing ligand (TRAIL)-mediated cytotoxicity on hematological malignancies. | 2001 | Secchiero, Paola; Gonelli, Arianna; Celeghini, Claudio; Mirandola, Prisco; Guidotti, L; Visani, G...; Capitani, Silvano; Zauli, Giorgio | file con accesso da definire |
All-Trans retinoic acid potentiates megakaryocyte colony formation: in vitro and in vivo effects after administration to acute promyelocytic leukemia patients | 1994 | Visani, G.; Zauli, G.; Tosi, P.; Ottaviani, E.; Gibellini, D.; Manfroi, S.; Celeghini, C.; Paglia...rini, C.; Bassini, A.; Tura, S. | file con accesso da definire |
An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction | 2006 | Secchiero, Paola; Corallini, Federica; Pandolfi, A; Consoli, A; Candido, R; Fabris, B; Celeghini,... C; Capitani, Silvano; Zauli, Giorgio | file con accesso da definire |
An update on the xenograft and mouse models suitable for investigating new therapeutic compounds for the treatment of B-cell malignancies | 2008 | Macor, P.; Secco, E.; Zorzet, S.; Tripodo, C.; Celeghini, C.; Tedesco, F. | file con accesso da definire |
Anti-leukemic activity of Dasatinib in both p53(wild-type) and p53 (mutated) B malignant cells. | 2012 | Bosco, Raffaella; Rabusin, M; Voltan, Rebecca; Celeghini, C; Corallini, Federica; Capitani, Silva...no; Secchiero, Paola | file con accesso da definire |
Association of PI 3-K with tyrosine phosphorylated Vav is essential for its activity in neutrophil-like maturation of myeloid cells | 2004 | Bertagnolo, Valeria; Brugnoli, Federica; Marchisio, Marco; Celeghini, Claudio; Carini, Cinzia; Ca...pitani, Silvano | |
Association of serum tumor necrosis factor-related apoptosis inducing ligand with body fat distribution as assessed by dual X-rays absorptiometry | 2014 | Cervellati, Carlo; Secchiero, Paola; Bonaccorsi, Gloria; Celeghini, C; Zauli, Giorgio | file con accesso da definire |
Ceramides as the molecular link between impaired lipid metabolism, saturated fatty acid intake and insulin resistance: are all saturated fatty acids to be blamed for ceramide-mediated lipotoxicity? | 2024 | Sergi, D.; Zauli, E.; Celeghini, C.; Previati, M.; Zauli, G. | file con accesso da definire |
Complement component C1q as potential diagnostic but not predictive marker of preeclampsia | 2016 | Agostinis, C.; Stampalija, T.; Tannetta, D.; Loganes, C.; Vecchi Brumatti, L.; De Seta, F.; Celeg...hini, C.; Radillo, O.; Sargent, I.; Tedesco, F.; Bulla, R. | |
Design, synthesis and biological characterization of novel mitochondria targeted dichloroacetate-loaded compounds with antileukemic activity | 2016 | Trapella, Claudio; Voltan, Rebecca; Melloni, Elisabetta; Tisato, Veronica; Celeghini, C; Bianco, ...Sara; Fantinati, Anna; Salvadori, Severo; Guerrini, Remo; Secchiero, Paola; Zauli, Giorgio | |
Dexamethasone counteracts the anti-osteoclastic, but not the anti-leukemic, activity of TNF-related apoptosis inducing ligand (TRAIL) | 2010 | Zauli, Giorgio; Rimondi, Erika; Celeghini, C; Milani, Daniela; Secchiero, Paola | file con accesso da definire |
Differential effects of chemotherapeutic drugs versus the MDM-2 antagonist nutlin-3 on cell cycle progression and induction of apoptosis in SKW6.4 lymphoblastoid B-cells | 2008 | Barbarotto, Elisa; Corallini, Federica; Rimondi, Erika; Fadda, Roberto; Mischiati, Carlo; Grill, ...V; Vaccarezza, M; Celeghini, Claudio | file con accesso da definire |
Differential effects of stromal derived factor-1 alpha (SDF-1alpha) on early and late stages of human megakaryocytic development. | 2000 | Secchiero, Paola; Celeghini, Claudio; Cutroneo, G; DI BALDASSARRE, A; Rana, R; Zauli, Giorgio | file con accesso da definire |
Effect of recombinant TRAIL in a murine co-culture system of osteoclastogenesis | 2008 | Nicolin, V; Narducci, P; Celeghini, C | file con accesso da definire |
Erythropoietin-induced erythroid differentiation of K562 cells is accompanied by the nuclear translocation of phosphatidylinositol 3-kinase and intranuclear generation of phosphatidylinositol (3,4,5) trisphosphate | 2002 | Neri, Luca Maria; Bortul, R; Tabellini, G; Borgatti, Paola; Baldini, G; Celeghini, Claudio; Capit...ani, Silvano; Martelli, Am | file con accesso da definire |
Extracellular Tat activates c-fos promoter in low serum-starved CD4+ T cells | 2001 | Gibellini, D; Re, Mc; Ponti, C; Celeghini, C; Melloni, E; LA PLACA, M; Zauli, G | file con accesso da definire |
Fine tuning of protein kinase C (PKC) isoforms in cancer: shortening the distance from the laboratory to the bedside. | 2011 | Bosco, Raffaella; Melloni, Elisabetta; Celeghini, C; Rimondi, Erika; Vaccarezza, M; Zauli, Giorgio | file con accesso da definire |
Functional expression of TRAIL and TRAIL-R2 during human megakaryocytic development | 2005 | Melloni, Elisabetta; Secchiero, Paola; Celeghini, C; Campioni, Diana; Grill, V; Guidotti, L; Zaul...i, Giorgio | file con accesso da definire |